Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
UN Integrated Regional Information Networks - September 11, 2001
Since the company announced its offer last year, it had been "frustrated" that few countries or health programmes came forward to accept the offer. But according to the Journal, a new application process developed by Dublin-based Axios International "addresses several major stumbling blocks that have impeded access to Viramune".
Under the application process, governments and private non-profit organisations must demonstrate that they can "manage the logistics of getting the medicines to the patients who need them." Axios CEO Joseph Saba said that the process "allows us to help determine how many mothers they can serve, and to overcome obstacles, such as import licenses and duties, that had been in the way."
Boehringer-Ingelheim has already shipped 18,600 doses of the drug to eight health programmes in the Democratic Republic of Congo (DRC), Rwanda, Zambia, Uganda, Senegal and Zimbabwe and expects to ship another 31,400 doses to seven health centres in six other countries. The company is reviewing applications from other programmes, including some in South Africa.
010911
IR010924
Copyright © 2001 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .